Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Single injections of RC-3095 produce prolonged reductions in EGF receptor number and expression

Dec. 4, 1997

Miravant reports promising interim phase III results for breast cancer trial

Dec. 4, 1997

Pfizer discontinues collaboration with Megabios

Dec. 3, 1997

VEGF receptor tyrosine kinase inhibitors under development at Zeneca

Dec. 3, 1997

Water-soluble taxanes reported in patent literature

Dec. 3, 1997

EntreMed reports positive preclinical results using Endostatin

Dec. 3, 1997

ALVAC-IL-12 gene therapy effective in murine model of breast cancer

Dec. 2, 1997

Heterocyclic antitumor agents from Dainippon

Dec. 2, 1997

Steroidal anticancer compounds isolated from C. africana

Dec. 2, 1997

Angiostatin production mechanism elucidated; may permit large-scale studies

Dec. 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...